Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Susie Hong is a Cardiologist in Baltimore,, Maryland. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. Her top areas of expertise are Mitral Valve Regurgitation, Familial Ventricular Tachycardia, Necrosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Robert Hood is a Cardiologist in Baltimore,, Maryland. Dr. Hood is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Familial Ventricular Tachycardia, Necrosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Richard (Rick) Carrick is a general cardiologist in the Johns Hopkins Division of Medicine and is an assistant professor of medicine at the Johns Hopkins School of Medicine. He also serves as associate director of the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. Originally from Massachusetts, he completed his medical training as well as a Ph.D. in Bioengineering at the University of Vermont and did his internal medicine residency training at Tufts Medical Center in Boston, MA. He completed his Cardiovascular Disease Fellowship and a T32 Research Fellowship at Johns Hopkins. His research focuses on the use of advanced computational techniques like machine-learning and artificial intelligence to improve risk stratification in patients with inherited heart disease. Clinically, he specializes in echocardiography and the care of patients with hypertrophic cardiomyopathy (HCM) and other genetic cardiomyopathies. Dr. Carrick is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Ventricular Tachycardia, Arrhythmias, and Cardiac Ablation.

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Maurizio Colognesi is a Cardiologist in Baltimore, Maryland. Dr. Colognesi is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Heart Failure, Heart Attack, Apoplexy, and Inappropriate Sinus Tachycardia (IST).

Dr. Thomas R. Aversano is an associate professor of medicine at Johns Hopkins University. He is also the associate chief of cardiology at Johns Hopkins Cardiology at GBMC and the director of the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). His research interests focus on health services research - public policy, cardiovascular disease treatment, coronary intervention, and patient outcomes research in cardiovascular disease. Dr. Aversano received an undergraduate degree from the University of Rochester and a medical degree from the University of Oklahoma. He was a resident of internal medicine as well as a research fellow in cardiology at S.U.N.Y. at Buffalo before joining Johns Hopkins University as a cardiology fellow in 1982. Dr. Aversano has contributed to Johns Hopkins InHealth, specifically the development of a cardiology program (inCar) within the InHealth initiative focused on creation of a real-time decision-support, communication, and documentation tool for interventional cardiology. He also created and leads the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) whose projects have involved 87 hospitals in 11 States and recruited more than 30,000 patients in randomized trials and registries. C-PORT worked with Departments of Health in 13 States to perform these studies. These projects were instrumental in changing both national heart association guidelines and State health care policy regarding performance of percutaneous coronary intervention (PCI). Dr. Aversano is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Familial Ventricular Tachycardia, Transient Ischemic Attack (TIA), Inappropriate Sinus Tachycardia (IST), Arrhythmias, and Percutaneous Coronary Intervention (PCI).

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Ilan Wittstein is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Baltimore, Maryland. Dr. Wittstein is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Cardiomyopathy, Arrhythmias, Familial Ventricular Tachycardia, Cardiac Ablation, and Heart Transplant. Dr. Wittstein is currently accepting new patients.

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Sammy Zakaria is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine (JHUSOM). Because he specializes in critical care cardiology, he predominately works in the Cardiac Intensive Care Unit (CICU) at the Johns Hopkins Bayview Medical Center (JHBMC) as well as the Cardiac Care Unit at Johns Hopkins Hospital (JHH). He also serves as the Director of the JHBMC CICU. His practice encompasses most of cardiology, with many of his patients having had life-threatening cardiac issues, such as shock, end-stage heart failure, or multi-organ system failure. He also has an interest in caring for pregnant women with cardiovascular disease, including those with severe preeclampsia, and his clinical research efforts focus on the effects of preeclampsia on the cardiovascular system. Additionally, his other research areas of interest include critical care issues affecting cardiac patients and studying innovations in medical education. Dr. Zakaria is heavily involved in medical education and serves as an educator for students, residents, fellows, and staff. He served as a JHUSOM Colleges Advisor for 10 years and was responsible for teaching and mentoring a cohort of medical students during their time in medical school. In his role as Interim Program Director for the JHBMC Internal Medicine Residency Program, he has helped to increase the JHBMC Internal Medicine residency program’s nationally-recognized reputation for excellence by championing curricular innovations, resident scholarly work, and resident academic careers. He also is a Core Faculty member for the JHH Osler Internal Medicine residency program and for the Johns Hopkins Cardiovascular Disease fellowship. As a result of his efforts in education, he has been honored with multiple teaching awards, including the Outstanding Achievement in Teaching Award from the Johns Hopkins Institute for Excellence in Education. Dr. Zakaria earned his undergraduate degree from the Pennsylvania State University, his medical degree from Jefferson Medical College, and his master of public health degree from the University of Maryland. He trained at Thomas Jefferson University Hospital in Internal Medicine and also practiced there as a faculty attending for one year. He then completed a fellowship in cardiovascular disease at the University of Maryland and subsequently a Critical Care Medicine fellowship at the University of California San Francisco. He joined the Johns Hopkins faculty in 2008. Dr. Zakaria is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Apoplexy, Heart Attack, Arterial Embolism, Inappropriate Sinus Tachycardia (IST), and Pacemaker Implantation.

Dr. Monica Mukherjee is an adult cardiologist and an Associate Professor of Medicine at the Johns Hopkins University Division of Cardiology and specializes in advanced cardiac imaging. She serves as Medical Director of the Echocardiography Lab at Johns Hopkins Bayview Medical Center, and as Associate Director of the Johns Hopkins Echocardiography program across the institution. Dr. Mukherjee graduated Summa Cum Laude with dual Bachelors of Science in Psychology and Behavioral Neurosciences from the University of Florida. She received her Doctorate in Medicine from the George Washington University in Washington, DC, and internal medicine residency at Drexel University, before returning to George Washington to complete her fellowship in cardiovascular disease. She has a MPH from the Johns Hopkins Bloomberg School of Public Health with a special concentration in Epidemiological and Biostatistical Methods for Public Health and Clinical Research. Dr. Mukherjee has an accomplished academic career with multiple research awards focused on right ventricular remodeling in heart failure, pulmonary hypertension, and scleroderma. She was the recipient of the 2020 Johns Hopkins University Clinician Scientist Award and also has been funded by the National Institutes of Health, the Scleroderma Foundation, and the CHEST Foundation. She was awarded the Top 25 Young Investigators Award from the American Society of Echocardiography in 2016. Dr. Mukherjee is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. Her top areas of expertise are Pulmonary Hypertension, Heart Attack, Systemic Sclerosis (SSc), Tissue Biopsy, and Pacemaker Implantation.

Dr. Johnston joined the Cardiology Faculty in 2008 and currently practices Interventional Cardiology at Johns Hopkins Hospital, Bayview Medical Center, and Johns Hopkins Howard County Medical Center. His primary research interest is in novel therapies for heart failure and he is involved in both clinical trials and pre-clinical studies currently underway at Johns Hopkins. Dr. Johnston is rated as an Advanced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI).

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as a Distinguished provider by MediFind in the treatment of Familial Ventricular Tachycardia. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Degrees: BS: Massachusetts Institute of Technology 1981 Electrical Engineering MS: Massachusetts Institute of Technology 1983 Electrical Engineering PhD: Massachusetts Institute of Technology 1987 Electrical Engineering MD: Harvard 1987 Medicine Professional Appointments: 1987-1988 Intern in Medicine, Brigham and Women's Hospital 1988-1990 Resident in Medicine, Brigham and Women's Hospital 1988-1990 Research Scientist, Harvard M.I.T. Division of H.S.T. 1990-1993 Fellow in Cardiology, Johns Hopkins University 1993-1998 Assistant Professor of Medicine, Johns Hopkins University 1996- Co-Director of Cardiac Electrophysiology, Johns Hopkins Hospital 1998-2005 Associate Professor of Medicine, Johns Hopkins University 2002-2005 Associate Professor of Biomedical Engineering, Johns Hopkins University 2005- Professor of Medicine, Johns Hopkins University 2005- Professor of Biomedical Engineering, Johns Hopkins University. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Familial Ventricular Tachycardia. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).